banner
Recombinant Escherichia coli sulfoquinovosidase 31A
Inquiry

Cat. No.: X23-08-YM321

Recombinant Escherichia coli sulfoquinovosidase 31A

Synonym: EcSqa31A

  • Enzyme Commission Number: 3.2.1.199
img
Product Size
1 mg; 2 mg; 3 mg; 6 mg
Price
Datasheet
MSDS
Properties
Description
Recombinant Escherichia coli sulfoquinovosidase 31A produced by Escherichia coli, specifically targets and removes sulfoquinovose (SQ) from the plant glycolipid sulfoquinovosyl diacylglyceride (SQDG).
Expression System
Escherichia coli
Species
Escherichia coli
Concentration
1 mg/mL
Form
Liquid
Purity
≥90%, determined by SDS-PAGE.
Activity
Other Activities
Buffer
35 mM NaHepes buffer (pH 7.5), 750 mM NaCl, 200 mM imidazole, 3.5 mM CaCl2, and 25% (v/v) glycerol
Applications
Recombinant Escherichia coli sulfoquinovosidase 31A can be used for glycobiology research. It has the ability to hydrolyze 4-nitrophenyl-α-sulfoquinovoside (PNPSQ), and sulfoquinovosyl diacylglyceride (SQDG).
Publications
Publications (0)

Publications

×
Publications

Thank you for choosing our products for your research. By sharing your publications or experimental feedback, you provide invaluable insights that help fellow scientists accelerate their discoveries. Your contribution also drives our commitment to continuous product optimization.

As a token of our appreciation, verified submissions will receive an exclusive discount code for your next order.

*Submitted research data and images may be featured on our product pages. We strictly protect your personal privacy; no sensitive contact information will ever be disclosed.

  • You can upload up to 5 images or ZIP files, and the size of a single file may not exceed 5MB.
Related Products
Quick Links

About Us

CD BioGlyco is a leading biotechnology company specializing in glycobiology. We deliver high-quality products and services to support cutting-edge research worldwide.

Contact Us

  • For research and manufacturing partners only. Not intended for (direct) human or veterinary use.
Copyright © CD BioGlyco. All rights reserved.